Supports capability built-up in microbial quality control in Pharma, and biopharma industry Merck invests €200,000 in the infrastructure of the new lab at Jigani
Merck announced the opening of its first Microbiology Application and Training (MAT) Lab in Jigani, Bengaluru, offering facilities and technical expertise to support the Indian life science community on microbial quality control capability development.
Veena Panicker, Head of BioMonitoring, Merck Life Science in India, said, “Merck’s MAT lab will be a space for pharma and biopharma companies to collaborate and enhance their capability in microbiology analysis. Partnering with our customers, we can support them in product demonstrations, hands-on training, formal bioprocessing educational courses and experiments, as well as apply best practices and new approaches to develop, optimise and scale-up processes and simplify global technology transfer,” Veena added.
With an investment of €200,000, the MAT Centre spans an area size of 1,100 sqft. The testing services offered in the Lab include sterility testing, rapid bioburden testing, pyrogen testing, advance membrane filtration and other pharma QC microbiology applications. The MAT Lab includes a vibrant space for certified training, application support, feasibility studies and method development for Pharma and Biopharma industries.
Sreenath NS, Country Speaker, Merck India and Managing Director, Merck Life Science. The newly launched MAT Lab is a space that enables pharmaceutical and biopharmaceutical manufacturers to work side-by-side with our global microbiology and application experts to solve critical process developments and production challenges.”
